{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:51:28Z","timestamp":1789203088795,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12010-022-04011-6","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T08:02:50Z","timestamp":1656403370000},"page":"5333-5352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Synchronous Investigation of the Mechanism and Substance Basis of Tripterygium Glycosides Tablets on Anti-rheumatoid Arthritis and Hepatotoxicity"],"prefix":"10.1007","volume":"194","author":[{"given":"Qi","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"4011_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/acr.20041","volume":"62","author":"JJ Sacks","year":"2010","unstructured":"Sacks, J. J., Luo, Y. H., & Helmick, C. G. (2010). Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001\u20132005. Arthritis Care and Research, 62, 460\u2013464.","journal-title":"Arthritis Care and Research"},{"key":"4011_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/ar2669","volume":"11","author":"SE Gabriel","year":"2009","unstructured":"Gabriel, S. E., & Michaud, K. (2009). Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Research & Therapy, 11, 229.","journal-title":"Arthritis Research & Therapy"},{"key":"4011_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/rheumatology\/39.suppl_2.3","volume":"39","author":"O Sangha","year":"2000","unstructured":"Sangha, O. (2000). Epidemiology of rheumatic diseases. Rheumatology, 39, 3\u201312.","journal-title":"Rheumatology"},{"key":"4011_CR4","doi-asserted-by":"crossref","unstructured":"Lin, Y. J., Anzaghe, M., & Sch\u00fclke, S. (2020). Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells, 9, 880.","DOI":"10.3390\/cells9040880"},{"key":"4011_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen, J. S., Landew\u00e9, R. B. M., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., et al. (2020). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases, 79, 685\u2013699.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"4011_CR6","doi-asserted-by":"crossref","first-page":"1567463","DOI":"10.1155\/2018\/1567463","volume":"2018","author":"J Wang","year":"2018","unstructured":"Wang, J., Chen, N., Fang, L., Feng, Z., Li, G., Mucelli, A., Zhang, X., & Zhou, X. (2018). A systematic review about the efficacy and safety of Tripterygium wilfordii Hook f preparations used for the management of rheumatoid arthritis. Evidence-based Complementary and Alternative Medicine., 2018, 1567463.","journal-title":"Evidence-based Complementary and Alternative Medicine."},{"key":"4011_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20587392211000885","volume":"19","author":"X Zhang","year":"2021","unstructured":"Zhang, X., & Zhou, X. (2021). Tripterygium glycoside improves regulatory T cells and attenuates acute organ dysfunction in septic mice. European Journal of Inflammation, 19, 1\u201310.","journal-title":"European Journal of Inflammation"},{"key":"4011_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3892\/br.2015.501","volume":"3","author":"A Cai","year":"2015","unstructured":"Cai, A., Qi, S., Su, Z., Shen, H., Ma, W., & Dai, Y. (2015). Tripterygium glycosides inhibit inflammatory mediators in the rat synovial RSC-364 cell line stimulated with interleukin-1\u03b2. Biomedical Reports, 3, 763\u2013766.","journal-title":"Biomedical Reports"},{"key":"4011_CR9","first-page":"3365","volume":"44","author":"XH Xiao","year":"2019","unstructured":"Xiao, X. H., & Liu, C. X. (2019). Collaborative innovation boosting the safe and rational use of traditional Chinese medicines. China Journal of Chinese Materia Medica, 44, 3365\u20133367.","journal-title":"China Journal of Chinese Materia Medica"},{"key":"4011_CR10","first-page":"791","volume":"45","author":"WJ Chen","year":"2020","unstructured":"Chen, W. J., Li, T. X., Wang, X. Y., Xue, Z. P., Lv, C., Li, H. Z., Li, Y. Q., Fan, Y. F., Tian, Y. G., Yang, J., Guo, M. Q., Wang, J. X., Wu, H. Y., Zhang, Y. Q., & Lin, N. (2020). Meta-analysis of RCT studies on clinical efficacy of single administration of Tripterygium glycosides tablets or combined administration with methotrexate against rheumatoid arthritis. China Journal of Chinese Materia Medica, 45, 791\u2013797.","journal-title":"China Journal of Chinese Materia Medica"},{"key":"4011_CR11","unstructured":"A Gudamu, Chen, W. W., Tang, H. Y., Yao, C. H., Huang, H. P., & Su, X. (2021). Research progress of Tripterygium wilfordii in the treatment of rheumatoid arthritis. Journal of Liaoning University of Traditional Chinese Medicine, 23, 118\u2013121."},{"key":"4011_CR12","first-page":"13","volume":"17","author":"PH Chen","year":"2017","unstructured":"Chen, P. H., & Cheng, J. F. (2017). Study progress of Tripterygium glycosides in treatment of inflammatory diseases. World. Latest. Med. Inf., 17, 13\u201314.","journal-title":"World. Latest. Med. Inf."},{"key":"4011_CR13","first-page":"3441","volume":"44","author":"JX Wang","year":"2019","unstructured":"Wang, J. X., Liu, C. F., Li, Y. Q., Su, X. H., Liu, L. L., Tian, Y. G., Wang, J. X., Jia, K. X., & Lin, N. (2019). Effect of Tripterygium Glycosides Tablets on synovial angiogenesis in rats with type II collagen induced arthritis. China Journal of Chinese Materia Medica, 44, 3441\u20133447.","journal-title":"China Journal of Chinese Materia Medica"},{"key":"4011_CR14","first-page":"746","volume":"45","author":"YQ Li","year":"2020","unstructured":"Li, Y. Q., Liu, C. F., Jia, K. X., Wang, J. X., Wang, J. X., Zhang, J. X., Zhu, H. W., Xu, T. T., Ming, R. R., Wang, T., & Lin, N. (2020). Comparative study on chronic multiple organ injury in normal rats caused by high dose of Tripterygium Glycosides Tablets from 6 different manufacturers. China Journal of Chinese Materia Medica, 45, 746\u2013754.","journal-title":"China Journal of Chinese Materia Medica"},{"key":"4011_CR15","first-page":"775","volume":"45","author":"YQ Li","year":"2020","unstructured":"Li, Y. Q., Hu, R. X., Jia, K. X., Wang, J. X., Xu, T. T., Cui, R. Z., Ming, R. R., Li, T. X., Liu, C. F., Liao, X., & Lin, N. (2020). Meta-analysis on safety of Tripterygium Glycosides Tablets in treatment of rheumatoid arthritis. China Journal of Chinese Materia Medica, 45, 775\u2013790.","journal-title":"China Journal of Chinese Materia Medica"},{"key":"4011_CR16","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/med.21762","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Mao, X., Li, W., Chen, W., Wang, X., Ma, Z., & Lin, N. (2021). Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment. Medicinal Research Reviews, 41, 1337\u20131374.","journal-title":"Medicinal Research Reviews"},{"key":"4011_CR17","doi-asserted-by":"publisher","first-page":"9148523","DOI":"10.1155\/2017\/9148523","volume":"2017","author":"S Wang","year":"2017","unstructured":"Wang, S., Li, R., He, S., He, L., Zhao, H., Deng, X., & Chen, Z. (2017). Tripterygium wilfordii Glycosides upregulate the new anti-inflammatory cytokine IL-37 through ERK1\/2 and p38 MAPK signal pathways. Evidence-based Complementary and Alternative Medicine, 2017, 9148523.","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"issue":"1","key":"4011_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3892\/mmr.2015.3448","volume":"12","author":"W Ji","year":"2015","unstructured":"Ji, W., Chen, Y. J., Zhao, X., Guo, Y. K., Zhong, L. Y., Li, H. G., Wang, D., & Song, Y. N. (2015). Beneficial effects of Tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis. Molecular Medicine Reports, 12(1), 684\u2013690.","journal-title":"Molecular Medicine Reports"},{"key":"4011_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12967-018-1549-9","volume":"16","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Wang, H., Mao, X., Guo, Q., Li, W., Wang, X., Li, G., & Lin, N. (2018). A novel gene-expression-signature-based model for prediction of response to Tripterysium glycosides tablet for rheumatoid arthritis patients. Journal of Translational Medicine, 16, 187.","journal-title":"Journal of Translational Medicine"},{"key":"4011_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2174\/1389200219666180302152752","volume":"19","author":"X Du","year":"2018","unstructured":"Du, X., Nyagblordzro, M., An, L., Gao, X., Du, L., Wang, Y., Ondieki, G., Kikete, S., & He, X. (2018). Pharmacokinetic and toxicological characteristics of tripterigium glycosides and their derivatives. Current Drug Metabolism, 19, 605\u2013627.","journal-title":"Current Drug Metabolism"},{"key":"4011_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jep.2011.03.007","volume":"135","author":"J Li","year":"2011","unstructured":"Li, J., Lu, Y., Xiao, C., Lu, C., Niu, X., He, X., Zhao, H., Tan, Y., & Lu, A. (2011). Comparison of toxic reaction of Tripterygium wilfordii multiglycoside in normal and adjuvant arthritic rats. Journal of Ethnopharmacology, 135, 270\u2013277.","journal-title":"Journal of Ethnopharmacology"},{"key":"4011_CR22","first-page":"3851","volume":"40","author":"XM Zhao","year":"2015","unstructured":"Zhao, X. M., Liu, X. Y., Chang, X., Tao, Y., Jin, C., Zhao, K. J., Ma, Z. J., & Xiao, X. H. (2015). Investigation of metabolites of Triptergium wilfordii on liver toxicity by LC-MS. China Journal of Chinese Materia Medica, 40, 3851\u20133858.","journal-title":"China Journal of Chinese Materia Medica"},{"key":"4011_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/bcpt.13313","volume":"126","author":"K Chen","year":"2020","unstructured":"Chen, K., Guo, N., Zhang, R., Wei, C., & Guo, R. (2020). CYP2E1 and miRNA-378a-3p contribute to acetaminophen- or tripterygium glycosides-induced hepatotoxicity. Basic & Clinical Pharmacology & Toxicology, 126, 153\u2013165.","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"4011_CR24","first-page":"1032","volume":"39","author":"XC Fu","year":"2019","unstructured":"Fu, X. C., Shen, X. L., Yu, H. P., Wu, Y. Y., & Jiang, P. (2019). An experimental study on promotion of hepatocyte apoptosis by Tripterygium glycosides in zebrafish. Chinese Journal of Hospital Pharmacy, 39, 1032\u20131038.","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"4011_CR25","doi-asserted-by":"publisher","first-page":"104190","DOI":"10.1016\/j.fitote.2019.104190","volume":"137","author":"HW Lv","year":"2019","unstructured":"Lv, H. W., Jiang, L. P., Zhu, M. D., Li, Y. X., Luo, M., Jiang, P. H., Tong, S. Q., Zhang, H. J., & Yan, J. Z. (2019). The genus Tripterygium: A phytochemistry and pharmacological review. Fitoterapia, 137, 104190.","journal-title":"Fitoterapia"},{"key":"4011_CR26","first-page":"12","volume":"48","author":"XY Zhang","year":"2020","unstructured":"Zhang, X. Y., Xin, G. Z., Liu, J. Q., & Liu, L. F. (2020). Identification of chemical constituents of Tripterygium Glycosides Tablets based on UPLC-QTOF\/MS. Acta Chinese Medicine and Pharmacology, 48, 12\u201320.","journal-title":"Acta Chinese Medicine and Pharmacology"},{"key":"4011_CR27","first-page":"2755","volume":"46","author":"J Chi","year":"2015","unstructured":"Chi, J., Lin, B., Liu, Z. H., Yang, L. N., & Song, H. T. (2015). Spectrum-effect relationship of immunosuppressive activity of Leigongteng Duogan tablet based on partial least squares regression analysis. Chinese Traditional and Herbal Drugs, 46, 2755\u20132758.","journal-title":"Chinese Traditional and Herbal Drugs"},{"key":"4011_CR28","first-page":"1479","volume":"40","author":"J Chi","year":"2015","unstructured":"Chi, J., Lin, B., Liu, Z. H., Yang, L. N., Liu, X. M., & Song, H. T. (2015). Fingerprint and spectrum-effect relationships on Tripterygium glycosides preparation. China Journal of Chinese Materia Medica, 40, 1479\u20131483.","journal-title":"China Journal of Chinese Materia Medica"},{"key":"4011_CR29","first-page":"1583","volume":"18","author":"JM Dong","year":"2016","unstructured":"Dong, J. M., Xu, C., Gong, M., Zhao, Q. G., Wang, J. B., Xiao, X. H., Ma, Z. J., & Pu, S. B. (2016). Study on effective components of roots of Tripterygium wilfordii based on spectrum-effect relationships analysis. Modern Chinese Medicine, 18, 1583\u20131588.","journal-title":"Mod. Chin. Med"},{"key":"4011_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.phymed.2018.03.031","volume":"54","author":"X Gao","year":"2019","unstructured":"Gao, X., Du, X., An, L. J., Wang, Y. Y., Wang, L. L., Wu, Z. G., Huang, C., & He, X. (2019). Wilforine, the Q-marker and PK-maker of Tripterygium glycosides tablet: Based on preparation quantitative analysis and PK-PD study. Phytomedicine, 54, 357\u2013364.","journal-title":"Phytomedicine"},{"key":"4011_CR31","doi-asserted-by":"publisher","first-page":"5276865","DOI":"10.1155\/2019\/5276865","volume":"2019","author":"W Hu","year":"2019","unstructured":"Hu, W., Fu, W. J., Wei, X., Yang, Y., Lu, C., & Liu, Z. Y. (2019). A network pharmacology study on the active ingredients and potential targets of Tripterygium wilfordii Hook for treatment of rheumatoid arthritis. Evidence-based Complementary and Alternative Medicine, 2019, 5276865.","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"4011_CR32","first-page":"1818","volume":"20","author":"PJ Yan","year":"2016","unstructured":"Yan, P. J., Zheng, C. S., Ye, H. Z., Zheng, L. X., & Bao, H. J. (2016). Pharmacodynamic material basis and molecular mechanism of Tripterygium wilfordii in treating rheumatoid arthritis based on computational simulation. Chinese Journal of Tissue Engineering Research, 20, 1818\u20131824.","journal-title":"Chinese Journal of Tissue Engineering Research"},{"key":"4011_CR33","first-page":"547","volume":"36","author":"X Wu","year":"2016","unstructured":"Wu, X., Lin, B., Wang, Z. Z., Liu, Z. H., & Song, H. T. (2016). Spectrum-effect relationship of immunosuppressive effects and toxicity of Tripterygium wilfordii HooK F. Chinese Journal of Hospital Pharmacy, 36, 547\u2013552.","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"4011_CR34","first-page":"2915","volume":"41","author":"XM Zhao","year":"2016","unstructured":"Zhao, X. M., Pu, S. B., Zhao, Q. G., Gong, M., Wang, J. B., Ma, Z. J., Xiao, X. H., & Zhao, K. J. (2016). Preliminary study on effective components of Tripterygium wilfordii for liver toxicity based on spectrum-effect correlation analysis. China Journal of Chinese Materia Medica, 41, 2915\u20132921.","journal-title":"China Journal of Chinese Materia Medica"},{"key":"4011_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40484-019-0167-8","volume":"7","author":"J Zhao","year":"2019","unstructured":"Zhao, J., Yang, J., Tian, S., & Zhang, W. D. (2019). A survey of web resources and tools for the study of TCM network pharmacology. Quantitative Biology, 7, 17\u201329.","journal-title":"Quantitative Biology"},{"key":"4011_CR36","doi-asserted-by":"publisher","first-page":"122769","DOI":"10.1016\/j.jchromb.2021.122769","volume":"1176","author":"M Wang","year":"2021","unstructured":"Wang, M., Xu, J., Zhang, Y., Yang, N., Ge, W., & Song, R. (2021). Integrated multiplatform-based metabonomics and network analysis to explore the mechanism of Polygonum cuspidatum on hyperlipidemia. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 1176, 122769.","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"4011_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jpba.2017.06.049","volume":"145","author":"Z Sui","year":"2017","unstructured":"Sui, Z., Qing, L., Lin, Z., Wang, Z., Lv, C., Ran Liu, HXu., He, B., Li, Z., & Bi, K. (2017). An integrative investigation of the toxicity of Aconiti kusnezoffii radix and the attenuation effect of its processed drug using a UHPLC-Q-TOF based rat serum and urine metabolomics strategy. Journal of Pharmaceutical and Biomedical Analysis, 145, 240\u2013247.","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"4011_CR38","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1021\/jf304625x","volume":"61","author":"C Li","year":"2013","unstructured":"Li, C., Sun, E., Zhang, Z., Qian, Q., Tan, X., Xu, F., & Jia, X. (2013). Metabolite profiles of epimedin B in rats by ultraperformance liquid chromatography\/quadrupole-time-of-flight mass spectrometry. Journal of Agriculture and Food Chemistry, 61, 3589\u20133599.","journal-title":"Journal of Agriculture and Food Chemistry"},{"key":"4011_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger, D., & de Groot, B. L. (2010). Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. Journal of Computer-Aided Molecular Design, 24, 417\u2013422.","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"4011_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrm2335","volume":"9","author":"MP Wymann","year":"2008","unstructured":"Wymann, M. P., & Schneiter, R. (2008). Lipid signalling in disease. Nature Reviews Molecular Cell Biology, 9, 162\u2013176.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"4011_CR41","doi-asserted-by":"publisher","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"JK Reddy","year":"2006","unstructured":"Reddy, J. K., & Rao, M. S. (2006). Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. American Journal of Physiology. Gastrointestinal and Liver Physiology, 290, G852\u2013G858.","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"4011_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun, Y. A., & Obeid, L. M. (2018). Sphingolipids and their metabolism in physiology and disease. Nature Reviews Molecular Cell Biology, 19, 175\u2013191.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"4011_CR43","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/14728222.2017.1332180","volume":"21","author":"A Meshcheryakova","year":"2017","unstructured":"Meshcheryakova, A., Mechtcheriakova, D., & Pietschmann, P. (2017). Sphingosine 1-phosphate signaling in bone remodeling: Multifaceted roles and therapeutic potential. Expert Opinion on Therapeutic Targets, 21, 725\u2013737.","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"4011_CR44","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00018-014-1778-x","volume":"72","author":"Z Khavandgar","year":"2015","unstructured":"Khavandgar, Z., & Murshed, M. (2015). Sphingolipid metabolism and its role in the skeletal tissues. Cellular and Molecular Life Sciences, 72, 959\u2013969.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"4011_CR45","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd4099","volume":"12","author":"GT Kunkel","year":"2013","unstructured":"Kunkel, G. T., Maceyka, M., Milstien, S., & Spiegel, S. (2013). Targeting the sphingosine-1phosphate axis in cancer, inflammation and beyond. Nature Reviews. Drug Discovery, 12, 688\u2013702.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"4011_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2017","unstructured":"Ogretmen, B. (2017). Sphingolipid metabolism in cancer signalling and therapy. Nature Reviews Cancer, 18, 33\u201350.","journal-title":"Nature Reviews Cancer"},{"key":"4011_CR47","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1517\/14728220903039722","volume":"13","author":"A Kumar","year":"2009","unstructured":"Kumar, A., & Saba, J. D. (2009). Lyase to live by: Sphingosine phosphate lyase as a therapeutic target. Expert Opinion on Therapeutic Targets, 13, 1013\u20131025.","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"4011_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S1388-1981(00)00079-2","volume":"1487","author":"PPV Veldhoven","year":"2000","unstructured":"Veldhoven, P. P. V., & Brys, V. (2000). Human sphingosine-1-phosphate lyase: CDNA cloning, functional expression studies and mapping to chromosome 10q22. Biochimica et Biophysica Acta, 1487, 128\u2013134.","journal-title":"Biochimica et Biophysica Acta"},{"key":"4011_CR49","doi-asserted-by":"publisher","first-page":"115087","DOI":"10.1016\/j.bone.2019.115087","volume":"130","author":"A El Jamal","year":"2020","unstructured":"El Jamal, A., Bougault, C., Mebarek, S., Magne, D., Cuvillier, O., & Brizuela, L. (2020). The role of sphingosine 1-phosphate metabolism in bone and joint pathologies and ectopic calcification. Bone, 130, 115087.","journal-title":"Bone"},{"key":"4011_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5507\/bp.2019.015","volume":"164","author":"K Huang","year":"2020","unstructured":"Huang, K., Li, W., Xiao, J., Luo, D., & Jin, J. (2020). Serum sphingosine negatively correlates with albumin predicting the risk of hepatocellular carcinoma. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic, 164, 203\u2013208.","journal-title":"Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic"},{"key":"4011_CR51","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1039\/b820224a","volume":"5","author":"P Yin","year":"2009","unstructured":"Yin, P., Wan, D., Zhao, C., Chen, J., Zhao, X., Wang, W., Lu, X., Yang, S., Gu, J., & Xu, G. (2009). A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Molecular BioSystems, 5, 868\u2013876.","journal-title":"Molecular BioSystems"},{"key":"4011_CR52","doi-asserted-by":"publisher","first-page":"117443","DOI":"10.1016\/j.lfs.2020.117443","volume":"247","author":"P Liu","year":"2020","unstructured":"Liu, P., Zhu, W., Chen, C., Yan, B., Zhu, L., Chen, X., & Peng, C. (2020). The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sciences, 247, 117443.","journal-title":"Life Sciences"},{"key":"4011_CR53","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1021\/np000504a","volume":"64","author":"HQ Duan","year":"2001","unstructured":"Duan, H. Q., Takaishi, Y., Momota, H., Ohmoto, Y., Taki, T., Jia, Y. F., & Li, D. (2001). Immunosuppressive sesquiterpene alkaloids from Tripterygium wilfordii. Journal of Natural Products, 64, 582\u2013587.","journal-title":"Journal of Natural Products"},{"key":"4011_CR54","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.fitote.2010.07.007","volume":"81","author":"M Xue","year":"2010","unstructured":"Xue, M., Jiang, Z. Z., Liu, J. P., Zhang, L. Y., Wang, T., Wang, H., Liu, L., & Zhou, Z. X. (2010). Comparative study on the anti-inflammatory and immune suppressive effect of Wilforlide A. Fitoterapia, 81, 1109\u20131112.","journal-title":"Fitoterapia"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04011-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-022-04011-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04011-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T23:05:47Z","timestamp":1727478347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-022-04011-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4011"],"URL":"https:\/\/doi.org\/10.1007\/s12010-022-04011-6","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"27 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors have their consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have their consent to publish their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}